Cognitive function in acromegaly: Description and brain volumetric correlates

Pituitary

Volumn 15, Issue 3, 2012, Pages 350-357

  Sievers, Caroline ^a   Samann P G ^a   Pfister, H ^a   Dimopoulou, C ^a   Czisch, M ^a   Roemmler, J ^a   Schopohl, J ^a   Stalla, G K ^a   Zihl, J ^a,b  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Acromegaly; Cognition; GH; IGF 1; MRI; Volumetry

Indexed keywords

ACROMEGALY; ADULT; ARTICLE; ATTENTION; ATTENTION DISTURBANCE; BRAIN SIZE; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE COURSE; EXECUTIVE FUNCTION; FEMALE; GRAY MATTER; HIPPOCAMPUS; HUMAN; MALE; MEMORY; MEMORY DISORDER; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; WHITE MATTER;

ACROMEGALY; ADULT; AGED; ATTENTION; BRAIN; COGNITION; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER; EXECUTIVE FUNCTION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS;

EID: 84867403415     PISSN: 1386341X     EISSN: 15737403     Source Type: Journal    
DOI: 10.1007/s11102-011-0326-z     Document Type: Article

References (34)

1. Sievers C, Dimopoulou C, Pfister H, Lieb R, Steffin B, Roemmler J, Schopohl J, Mueller M, Schneider HJ, Ising M, Wittchen HU, Stalla GK (2009) Prevalence of DSMIV mental disorders in acromegaly: a cross-sectional study in 81 acromegalic patients. Clin Endocrinol (Oxf) 71:691-701
2. Tanriverdi F, Yapislar H, Karaca Z, Unluhizarci K, Suer C, Kelestimur F (2009) Evaluation of cognitive performance by using P300 auditory event related potentials (ERPs) in patients with growth hormone (GH) deficiency and acromegaly. Growth Horm IGF Res 19:24-30
3. Leon-Carrion J, Martin-Rodriguez JF, Madrazo-Atutxa A, Soto-Moreno A, Venegas-Moreno E, Torres-Vela E, Benito-Lopez P, Galvez MA, Tinahones FJ, Leal-Cerro A (2010) Evidence of cognitive and neurophysiological impairment in patients with untreated naive acromegaly. J Clin Endocrinol Metab 95:4367-4379
4. Rowles SV, Prieto L, Badia X, Shalet SM, Webb SM, Trainer PJ (2005) Quality of life (QOL) in patients with acromegaly is severely impaired: use of a novel measure of QOL: acromegaly quality of life questionnaire. J Clin Endocrinol Metab 90:3337-3341
5. Biermasz NR, van Thiel SW, Pereira AM, Hoftijzer HC, van Hemert AM, Smit JW, Romijn JA, Roelfsema F (2004) Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess. J Clin Endocrinol Metab 89:5369-5376
6. Carro E, Torres-Aleman I (2006) Serum insulin-like growth factor I in brain function. Keio J Med 55:59-63
7. Carro E, Trejo JL, Fernandez S, Fernandez AM, Torres-Aleman I (2005) IGF-1 and neuroprotection. Academic Press, London
8. Clayton PE, Ayoola O, Whatmore AJ (2006) Patient selection for IGF-I therapy. Horm Res 65(Suppl 1):28-34
9. Sievers C, Schneider HJ, Stalla GK (2008) Insulin-like growth factor-1 in plasma and brain: regulation in health and disease. Front Biosci 13:85-99
10. Aberg ND, Brywe KG, Isgaard J (2006) Aspects of growth hormone and insulin-like growth factor-I related to neuroprotection, regeneration, and functional plasticity in the adult brain. Sci World J 6:53-80
11. Le Greves M, Le Greves P, Nyberg F (2005) Age-related effects of IGF-1 on the NMDA-, GH-and IGF-1-receptor mRNA transcripts in the rat hippocampus. Brain Res Bull 65:369-374
12. Arwert LI, Veltman DJ, Deijen JB, Lammertsma AA, Jonker C, Drent ML (2005) Memory performance and the growth hormone/ insulin-like growth factor axis in elderly: a positron emission tomography study. Neuroendocrinology 81:31-40
13. Arwert LI, Deijen JB, Drent ML (2005) The relation between insulin-like growth factor I levels and cognition in healthy elderly: a meta-analysis. Growth Horm IGF Res 15:416-422
14. Aleman A, Verhaar HJ, De Haan EH, De Vries WR, Samson MM, Drent ML, Van der Veen EA, Koppeschaar HP (1999) Insulin-like growth factor-I and cognitive function in healthy older men. J Clin Endocrinol Metab 84:471-475
15. Aleman A, de Vries WR, de Haan EH, Verhaar HJ, Samson MM, Koppeschaar HP (2000) Age-sensitive cognitive function, growth hormone and insulin-like growth factor 1 plasma levels in healthy older men. Neuropsychobiology 41:73-78
16. Sievers C, Sämann PG, Dose T, Dimopoulou C, Spieler D, Roemmler J, Schopohl J, Mueller M, Schneider HJ, Czisch M, Pfister H, Stalla GK (2009) Macroscopic brain architecture changes and white matter pathology in acromegaly: a clinicoradiological study. Pituitary 12:177-185
17. Reppermund S, Zihl J, Lucae S, Horstmann S, Kloiber S, Holsboer F, Ising M (2007) Persistent cognitive impairment in depression: the role of psychopathology and altered hypothalamic-pituitary-adrenocortical (HPA) system regulation. Biol Psychiatry 62:400-406
18. Whitmer RA (2007) Type 2 diabetes and risk of cognitive impairment and dementia. Curr Neurol Neurosci Rep 7:373-380
19. Shlyakhto E (2007) Observational Study on Cognitive function And systolic blood pressure Reduction (OSCAR): preliminary analysis of 6-month data from[10,000 patients and review of the literature. Curr Med Res Opin 23(Suppl 5):S13-S18
20. Inkster B, Nichols TE, Saemann PG, Auer DP, Holsboer F, Muglia P, Matthews PM (2009) Association of GSK3beta polymorphisms with brain structural changes in major depressive disorder. Arch Gen Psychiatry 66:721-728
21. Inkster B, Nichols TE, Saemann PG, Auer DP, Holsboer F, Muglia P, Matthews PM (2010) Pathway-based approaches to imaging genetics association studies: Wnt signaling, GSK3beta substrates and major depression. Neuroimage 53:908-917
22. Giustina A, Barkan A, Casanueva FF, Cavagnini F, Frohman L, Ho K, Veldhuis J, Wass J, Von Werder K, Melmed S (2000) Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab 85:526-529
23. van der Lely AJ, Beckers A, Daly AF, Lamberts SWJ, Clemmons DR (2005) Acromegaly: pathology diagnosis and treatment. Taylor&Francis, Boca Raton
24. Zimmermann PF (1993)B:Testbatterie zurAufmerksamkeitsprüfung (TAP) (Version 1.02c), Freiburg
25. Brickenkamp R (2002) Test d2. Aufmerksamkeits-Belastungs-Test (9th revised version), Göttingen
26. Gatterer G (1990) Alters-Konzentrationstest (AKT), Göttingen
27. Wechsler D (2000) Wechsler-Gedächtnistest-Revidierte Fassung, Bern
28. Lezak MD, Howieson DB, Loring DW (2004) Neuropsychological assessment, Oxford
29. Helmstaedter C, Lendt M, Lux S (2001) VLMT-Verbaler Lernund Merkfähigkeitstest, Göttingen
30. Raven J, Court J, Raven J Jr (1988) Standard progressive matrices. Weinheim, Beltz Test Gesellschaft
31. Aschenbrenner S, Tucha O, Lange KW (2000) Regensburger Wortflüssigkeitstest. Göttingen, Hogrefe
32. Eickhoff SB, Stephan KE, Mohlberg H, Grefkes C, Fink GR, Amunts K, Zilles K (2005) A new SPM toolbox for combining probabilistic cytoarchitectonic maps and functional imaging data. Neuroimage 25:1325-1335
33. Colao A, Ferone D, Marzullo P, Lombardi G (2004) Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 25:102-152
34. Etgen T, Bronner M, Sander D, Bickel H, Sander K, Forstl H (2009) Somatic factors in cognitive impairment. Fortschr Neurol Psychiatr 77:72-82